Impact Biomedical

IBONYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$56.886 M

$0.53 -5.06%

Close of 22 Sept 2026

Revenue

$32.0K

#3618 by revenue

Earnings

-$11.8M

Loss-making

Shares outstanding

107,821,231

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#347Xilio TherapeuticsXLO$59.5M
#348Serina TherapeuticsSER$58.7M
#349Impact BiomedicalIBO$56.9M
#350Heron TherapeuticsHRTX$56.8M
#351Edesa BiotechEDSA$55.0M

What if Impact Biomedical were worth as much as…

Open the what-if tool →

Gold $30.2T

$280,408.32

Per share 531,479× higher

Bitcoin $1.74T

$16,153.17

Per share 30,616× higher

Nvidia $5.52T

$51,156.59

Per share 96,961× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Impact Biomedical are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.